Children
Sign in to add trainee| Robert P. Hymes | grad student | Columbia (History of History Tree) | |
| Yiching Wu | grad student | Columbia (LinguisTree) | |
| Aihwa Ong | grad student | 1982 | Columbia |
| Eugene Murphy | grad student | 1994 | Columbia |
| Gregory Ruf | grad student | 1994 | Columbia |
| Dee Mack Williams | grad student | 1996 | Columbia |
| Hong Zhang | grad student | 1998 | Columbia |
| Isabelle Rey-Lescure | grad student | 1999 | Columbia |
| Shao-hua Liu | grad student | 2007 | Columbia |
| Ka-ming Wu | grad student | 2007 | Columbia |
| Drew Hopkins | grad student | 2008 | Columbia |
| Yi Wu | grad student | 2010 | Columbia |
| Guangtian Ha | grad student | 2014 | Columbia |
| Yixin Li | grad student | 2014 | Columbia |
| Diana Szatkowski | grad student | 2015 | Columbia |
| Tzu-chi Ou | grad student | 2018 | Columbia |
| Matthew West | grad student | 2019 | Columbia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Theodore DA, Neradilek M, Gillespie K, et al. (2025) Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085. Journal of Acquired Immune Deficiency Syndromes (1999). 98: 340-345 |
| Fogel JM, Persaud D, Piwowar-Manning E, et al. (2024) HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084. Aids Research and Human Retroviruses |
| Cohen MS. (2024) Evolution of Prevention of HIV: A Personal Journey. Sexually Transmitted Diseases. 51: 607-608 |
| Landovitz RJ, Delany-Moretlwe S, Fogel JM, et al. (2024) Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. The New England Journal of Medicine |
| Cantos VD, Neradilek M, Huang Y, et al. (2024) Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials. Open Forum Infectious Diseases. 11: ofae387 |
| Fogel JM, Piwowar-Manning E, Moser A, et al. (2024) Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiology Spectrum. e0030724 |
| Juraska M, Bai H, deCamp AC, et al. (2024) Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proceedings of the National Academy of Sciences of the United States of America. 121: e2308942121 |
| Hall M, Golubchik T, Bonsall D, et al. (2023) Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. The Lancet. Microbe |
| Huang Y, Zhang L, Karuna S, et al. (2023) Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01. Nature Communications. 14: 7813 |
| Landovitz RJ, Hanscom BS, Clement ME, et al. (2023) Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. The Lancet. Hiv |